MARKSANS PHARMA Q3 FY24 Results

MARKSANS PHARMA has released its financial results for the Q3 quarter of Financial Year 23-2024. Here's a comprehensive breakdown of the company's performance:

Revenue Analysis

• Current Quarter Revenue: Rs. 586.13 Cr
• Quarter-on-Quarter (QoQ) Change: 10.33% (Previous Quarter: Rs. 531.24 Cr )
• Year-on-Year (YoY) Change: 22.15% (Same Quarter Last Year: Rs. 479.83 Cr )

Profitability Metrics

• Net Profit: Rs. 82.97 Cr
• QoQ Profit Change: -1.06% (Previous Quarter: Rs. 83.85 Cr )
• YoY Profit Change: 33.16% (Same Quarter Last Year: Rs. 62.31 Cr )

Shareholder Returns

• Earnings Per Share (EPS): Rs. 1.84
• QoQ EPS Change: 0.00% (Previous Quarter: Rs. 1.84)
• YoY EPS Change: 17.95% (Same Quarter Last Year: Rs. 1.56)

Performance Summary

Excellent

MARKSANS PHARMA did very well, with profits growing faster than sales. This means they're managing costs better.

This analysis provides a snapshot of MARKSANS PHARMA's financial performance. Investors and analysts should consider these results in the context of broader market trends and the company's long-term strategy.